REFERENCES
1. Portman D.J., Gass M.L. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014; 21 (10): 1063-8. DOI: https://doi.org/10.1097/GME.0000000000000329
2. Balan V.E., Kovaleva L.A., Tikhomirova E.V. Genitourinary or urogen-tical syndrome: possibilities of long-term therapy. Meditsinskiy sovet [Medical Advice]. 2016; (12): 98-101. DOI: https://doi.org/10.21518/2079-701X-2016-12-98-101 (in Russian)
3. Shifren J.L. Genitourinary Syndrome of Menopause. Clin Obstet Gynecol. 2018; 61 (3): 508-16. DOI: https://doi.org/10.1097/GRF.0000000000000380
4. Gandhi J., Chen A. Dagur G., Suh Y., Smith N., Cali B., Khan S.A. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016; Vol. 215 (6): 704-11. DOI: https://doi.org/10.1016/j.ajog.2016.07.045
5. Moral E., Delgado J.L., Carmona F., Caballero B., Guillan C, Gonzalez PM, et al. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018; 21 (2): 167-73. DOI: https://doi.org/10.1080/13697137.2017.1421921
6. Monz D., Pons M., Hampel C., Hunskaer S., Quail D., Samsioe G. Sykes D., Wagg A. Papanicolaou S. Patient-repoted impact of urinary incontinence. Results from treatment seeking women in 14 European countries. Maturitas. 2005; 52 (2): 25-8.
7. Ermakova E.I., Balan V.E., Tikhomirova E.V., Lazareva I.N., Lapina A.V., Panina E.M. Genitourinary syndrome of menopause: diagnosis and principles of treatment (brief clinical recommendations). Rossiyskiy vestnik akushera-ginekologa [Russian Bulletin of Obstetrician-Gynecologist]. 2017; 17 (6): 89-95. (in Russian)
8. Apolikhina I.A., Yureneva S.V., Malyshkina D.A. Genitourinary syndrome of menopause: contemporary approaches to diagnosis and management. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. Supplement “Diagnostic and Treatment Algorithms”. 2020; 12: 14-8. (in Russian)
9. Angelou K., Grigoriadis T., Diakosavvas M. Zacharakis D., Athana-siou S. The Genitourinary Syndrome of Menopause: An Overview of the Recent Data. Cureus. 2020; 12 (4): 7586. DOI: https://doi.org/10.7759/cureus.7586
10. Smetnik V.P. Yureneva S.V. Ermakova E.I. Glazunova A.V. Genitourinary menopausal syndrome. Diagnostics and treatment (draft clinical protocol). Klimakteriy [Menopause]. 2015; 1. (in Russian)
11. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020; 27 (9): 976-92. DOI: http://dx.doi.org/10.1097/GME.0000000000001609
12. Palacios S., Mejfa A., Neyro J.L. Treatment of the genitourinary syndrome of menopause. Climacteric. 2015; 18 (Suppl 1): 23-9. DOI: https://doi.org/10.3109/13697137.2015.1079100
13. Palacios S., Combalia J., Emsellem C., Gaslain Y., Khorsandi D. Therapies for the management of genitourinary syndrome of menopause. Post Reprod Health. 2020; 26 (1): 32-42. DOI: https://doi.org/10.1177/2053369119866341
14. Baber R.J., Panay N., Fenton A. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016; 19 (2): 109-50. DOI: https://doi.org/10.3109/13697137.2015.1129166
15. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017; 24 (7): 728-53. DOI: https://doi.org/10.1097/GME.0000000000000921
16. Gambacciani M., Biglia N., Cagnacci A., Caruso S., Cicinelli E, DE Leo V, et al. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society. Minerva Ginecol. 2018; 70 (1): 27-34. DOI: https://doi.org/10.23736/S0026-4784.17.04151-X
17. Mercier J., Morin M., Tang A., Reichetzer B., Lemieux M.-C., Samir K., Zaki D., Gougeon F., Dumoulin C. Pelvic floor muscle training: mechanisms of action for the improvement of genitourinary syndrome of menopause. Climacteric. 2020; 23 (5): 468-73. DOI: http://dx.doi.org/10.1080/13697137.2020.1724942
18. Mercier J., Melanie M., Zaki D., Reichetzer B., Lemieux M.-C., Khalife S., Dumoulin C. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: A single-arm feasibility study. Maturitas. 2019; 125: 57-62. http://dx.doi.org/10.1016/j.maturitas.2019.03.002
19. Filippini M., Luvero D., Salvatore S., Pieralli A., Montera R., Plotti F., Candiani M., Angioli R. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study. Menopause. 2020; 27 (1): 43-9. DOI: http://dx.doi.org/10.1097/GME.0000000000001428
20. Paraiso M.F.R., Ferrando C.A., Sokol E.R., Rardin C.R., Matthews C.A., Karram M.M, Iglesia C.B. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial. Menopause. 2020; 27 (1): 50-6. DOI: http://dx.doi.org/10.1097/GME.0000000000001416
21. Elia D., Gambacciani M.M, Berreni N, Bohbot J.M., Druckmann R., Geoffrion H., Haab F., Heiss N., Rygaloff N., Russo E. Genitourinary syndrome of menopause (GSM) and laser VEL: a review. Horm Mol Biol Clin Investig. 2019; 41 (1). DOI: http://dx.doi.org/10.1515/hmbci-2019-0024
22. Cassani C., Martini E., Zanellini F., Nappi R.E. et.al. Use of a new low-energy dynamic quadripolar radiofrequency (dqrf) device in the treatment of symptoms of vulvo-vaginal atrophy (VVA) in natural menopausal women and breast cancer survivors. 16th World Congress on Menopause, 2018.
23. Fasola E., Bosoni D. Dynamic Quadripolar Radiofrequency: Pilot Study of a New High-Tech Strategy for Prevention and Treatment of Vulvar Atrophy. Aesthet Surg J. 2019; 39 (5): 544-52. DOI: http://dx.doi.org/10.1093/asj/sjy180
24. Vicariotto F., De Seta F., Faoro V., Raichi M. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety. Minerva Ginecol. 2017; 69 (4): 342-9. DOI: https://doi.org/10.23736/S0026-4784.17.04072-2. PMID: 28608667
25. Tranchini R., Raichi M. Ultra-Pulsed Radioporation further enhances the efficacy of Dynamic Quadripolar RadioFrequency in women with post-menopausal vulvo-vaginal atrophy. Clin Obstet Gynecol Re-prod Med. 2018; 4 (3): 1-5. DOI: https://doi.org/10.15761/COGRM.1000221.
26. Seregina E.M. EVA ™ - quadripolar dynamic RF-technology for the treatment of urogynecological diseases and aesthetic remodeling of the vulva and vagina. Kosmetika i meditsina [Cosmetics and Medicine]. 2019; (4): 62-8. (in Russian)
27. Prestia V., Bertozzi E., Raichi M. An exploratory, prospective cohort study of non-invasive dynamic quadripolar radiofrequency energy in vulvar lichen management. The new-generation DQRF™ option. Obstet Gynecol Rep. 2021; 5: 1-5. DOI: https://doi.org/10.15761/OGR.10